HEADER HYDROLASE/HYDROLASE INHIBITOR 13-OCT-10 3P8E TITLE CRYSTAL STRUCTURE OF HUMAN DIMETHYLARGININE DIMETHYLAMINOHYDROLASE-1 TITLE 2 (DDAH-1) COVALENTLY BOUND WITH N5-(1-IMINOPENTYL)-L-ORNITHINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: N(G),N(G)-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DDAH-1, DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1, DDAHI, COMPND 5 DIMETHYLARGININASE-1; COMPND 6 EC: 3.5.3.18; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DDAH, DDAH1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A-HDDAH-1 KEYWDS DDAH, NITRIC OXIDE SYNTHASE REGULATION, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.LLUIS,Y.WANG,A.F.MONZINGO,W.FAST,J.D.ROBERTUS REVDAT 4 06-SEP-23 3P8E 1 REMARK SEQADV LINK REVDAT 3 12-JAN-11 3P8E 1 JRNL REVDAT 2 17-NOV-10 3P8E 1 HEADER KEYWDS REVDAT 1 10-NOV-10 3P8E 0 JRNL AUTH M.LLUIS,Y.WANG,A.F.MONZINGO,W.FAST,J.D.ROBERTUS JRNL TITL CHARACTERIZATION OF C-ALKYL AMIDINES AS BIOAVAILABLE JRNL TITL 2 COVALENT REVERSIBLE INHIBITORS OF HUMAN DDAH-1. JRNL REF CHEMMEDCHEM V. 6 81 2011 JRNL REFN ISSN 1860-7179 JRNL PMID 20979083 JRNL DOI 10.1002/CMDC.201000392 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.060 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 18442 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.308 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 951 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.7557 - 4.7688 0.98 2634 153 0.1661 0.2563 REMARK 3 2 4.7688 - 3.7865 0.95 2550 131 0.1797 0.2635 REMARK 3 3 3.7865 - 3.3083 0.83 2189 130 0.2225 0.3115 REMARK 3 4 3.3083 - 3.0060 0.98 2591 157 0.2401 0.3349 REMARK 3 5 3.0060 - 2.7906 0.97 2553 113 0.2571 0.3943 REMARK 3 6 2.7906 - 2.6261 0.96 2517 131 0.2649 0.3655 REMARK 3 7 2.6261 - 2.4946 0.94 2457 136 0.2683 0.4021 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.28 REMARK 3 B_SOL : 23.76 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.780 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.710 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.93020 REMARK 3 B22 (A**2) : 3.31760 REMARK 3 B33 (A**2) : -5.24780 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.43730 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4276 REMARK 3 ANGLE : 1.195 5776 REMARK 3 CHIRALITY : 0.070 672 REMARK 3 PLANARITY : 0.004 750 REMARK 3 DIHEDRAL : 19.030 1628 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3P8E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1000062085. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : VARIMAX HIGH FLUX OPTICS REMARK 200 OPTICS : VARIMAX HIGH FLUX OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18983 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.495 REMARK 200 RESOLUTION RANGE LOW (A) : 73.794 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.57500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.970 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3I2E REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% POLYETHYLENEGLYCOL 6000, 0.1 M REMARK 280 TRIS-HCL, PH 8.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.45000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 IN LINKING N5-(1-IMINOPENTYL)-L-ORNITHINE TO CYS 274 THE REMARK 400 HYBRIDIZATION STATE OF CZ CHANGES FROM SP2 TO SP3 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -22 REMARK 465 GLY A -21 REMARK 465 SER A -20 REMARK 465 SER A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 SER A -12 REMARK 465 SER A -11 REMARK 465 GLY A -10 REMARK 465 LEU A -9 REMARK 465 VAL A -8 REMARK 465 PRO A -7 REMARK 465 ARG A -6 REMARK 465 GLY A -5 REMARK 465 SER A -4 REMARK 465 HIS A -3 REMARK 465 MET A -2 REMARK 465 ALA A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLY A 3 REMARK 465 LEU A 4 REMARK 465 GLY A 5 REMARK 465 HIS A 6 REMARK 465 PRO A 7 REMARK 465 ALA A 8 REMARK 465 ALA A 33 REMARK 465 LYS A 34 REMARK 465 VAL A 283 REMARK 465 ASP A 284 REMARK 465 SER A 285 REMARK 465 MET B -22 REMARK 465 GLY B -21 REMARK 465 SER B -20 REMARK 465 SER B -19 REMARK 465 HIS B -18 REMARK 465 HIS B -17 REMARK 465 HIS B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 SER B -12 REMARK 465 SER B -11 REMARK 465 GLY B -10 REMARK 465 LEU B -9 REMARK 465 VAL B -8 REMARK 465 PRO B -7 REMARK 465 ARG B -6 REMARK 465 GLY B -5 REMARK 465 SER B -4 REMARK 465 HIS B -3 REMARK 465 MET B -2 REMARK 465 ALA B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 GLY B 3 REMARK 465 LEU B 4 REMARK 465 GLY B 5 REMARK 465 HIS B 6 REMARK 465 PRO B 7 REMARK 465 ALA B 8 REMARK 465 ALA B 33 REMARK 465 LYS B 34 REMARK 465 VAL B 283 REMARK 465 ASP B 284 REMARK 465 SER B 285 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 243 C - N - CA ANGL. DEV. = 9.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 31 -148.65 -156.76 REMARK 500 GLU A 85 -118.56 58.57 REMARK 500 GLU A 137 -173.29 -172.65 REMARK 500 ASP A 170 30.29 70.83 REMARK 500 LEU A 172 -161.58 -126.19 REMARK 500 ASN A 184 -6.17 65.76 REMARK 500 MET A 262 27.98 -158.02 REMARK 500 ARG B 31 -112.69 -153.37 REMARK 500 GLU B 85 -123.82 64.11 REMARK 500 PHE B 158 69.10 -106.07 REMARK 500 ASP B 170 37.41 74.00 REMARK 500 ASP B 206 30.35 -72.14 REMARK 500 HIS B 207 -171.75 169.07 REMARK 500 ASN B 229 12.40 56.48 REMARK 500 MET B 262 41.67 -152.39 REMARK 500 LEU B 271 -165.07 -111.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LN7 A 286 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LN7 B 286 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3I2E RELATED DB: PDB REMARK 900 HUMAN DDAH-1 REMARK 900 RELATED ID: 3I4A RELATED DB: PDB REMARK 900 HUMAN DDAH-1 BOUND WITH N5-(1-IMINOPROPYL)-L-ORNITHINE REMARK 900 RELATED ID: 3P8P RELATED DB: PDB REMARK 900 HUMAN DDAH-1 BOUND WITH N5-(1-IMINOPENTYL)-L-ORNITHINE DBREF 3P8E A 1 285 UNP O94760 DDAH1_HUMAN 1 285 DBREF 3P8E B 1 285 UNP O94760 DDAH1_HUMAN 1 285 SEQADV 3P8E MET A -22 UNP O94760 EXPRESSION TAG SEQADV 3P8E GLY A -21 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER A -20 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER A -19 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS A -18 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS A -17 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS A -16 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS A -15 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS A -14 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS A -13 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER A -12 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER A -11 UNP O94760 EXPRESSION TAG SEQADV 3P8E GLY A -10 UNP O94760 EXPRESSION TAG SEQADV 3P8E LEU A -9 UNP O94760 EXPRESSION TAG SEQADV 3P8E VAL A -8 UNP O94760 EXPRESSION TAG SEQADV 3P8E PRO A -7 UNP O94760 EXPRESSION TAG SEQADV 3P8E ARG A -6 UNP O94760 EXPRESSION TAG SEQADV 3P8E GLY A -5 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER A -4 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS A -3 UNP O94760 EXPRESSION TAG SEQADV 3P8E MET A -2 UNP O94760 EXPRESSION TAG SEQADV 3P8E ALA A -1 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER A 0 UNP O94760 EXPRESSION TAG SEQADV 3P8E MET B -22 UNP O94760 EXPRESSION TAG SEQADV 3P8E GLY B -21 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER B -20 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER B -19 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS B -18 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS B -17 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS B -16 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS B -15 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS B -14 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS B -13 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER B -12 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER B -11 UNP O94760 EXPRESSION TAG SEQADV 3P8E GLY B -10 UNP O94760 EXPRESSION TAG SEQADV 3P8E LEU B -9 UNP O94760 EXPRESSION TAG SEQADV 3P8E VAL B -8 UNP O94760 EXPRESSION TAG SEQADV 3P8E PRO B -7 UNP O94760 EXPRESSION TAG SEQADV 3P8E ARG B -6 UNP O94760 EXPRESSION TAG SEQADV 3P8E GLY B -5 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER B -4 UNP O94760 EXPRESSION TAG SEQADV 3P8E HIS B -3 UNP O94760 EXPRESSION TAG SEQADV 3P8E MET B -2 UNP O94760 EXPRESSION TAG SEQADV 3P8E ALA B -1 UNP O94760 EXPRESSION TAG SEQADV 3P8E SER B 0 UNP O94760 EXPRESSION TAG SEQRES 1 A 308 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 308 LEU VAL PRO ARG GLY SER HIS MET ALA SER MET ALA GLY SEQRES 3 A 308 LEU GLY HIS PRO ALA ALA PHE GLY ARG ALA THR HIS ALA SEQRES 4 A 308 VAL VAL ARG ALA LEU PRO GLU SER LEU GLY GLN HIS ALA SEQRES 5 A 308 LEU ARG SER ALA LYS GLY GLU GLU VAL ASP VAL ALA ARG SEQRES 6 A 308 ALA GLU ARG GLN HIS GLN LEU TYR VAL GLY VAL LEU GLY SEQRES 7 A 308 SER LYS LEU GLY LEU GLN VAL VAL GLU LEU PRO ALA ASP SEQRES 8 A 308 GLU SER LEU PRO ASP CYS VAL PHE VAL GLU ASP VAL ALA SEQRES 9 A 308 VAL VAL CYS GLU GLU THR ALA LEU ILE THR ARG PRO GLY SEQRES 10 A 308 ALA PRO SER ARG ARG LYS GLU VAL ASP MET MET LYS GLU SEQRES 11 A 308 ALA LEU GLU LYS LEU GLN LEU ASN ILE VAL GLU MET LYS SEQRES 12 A 308 ASP GLU ASN ALA THR LEU ASP GLY GLY ASP VAL LEU PHE SEQRES 13 A 308 THR GLY ARG GLU PHE PHE VAL GLY LEU SER LYS ARG THR SEQRES 14 A 308 ASN GLN ARG GLY ALA GLU ILE LEU ALA ASP THR PHE LYS SEQRES 15 A 308 ASP TYR ALA VAL SER THR VAL PRO VAL ALA ASP GLY LEU SEQRES 16 A 308 HIS LEU LYS SER PHE CYS SER MET ALA GLY PRO ASN LEU SEQRES 17 A 308 ILE ALA ILE GLY SER SER GLU SER ALA GLN LYS ALA LEU SEQRES 18 A 308 LYS ILE MET GLN GLN MET SER ASP HIS ARG TYR ASP LYS SEQRES 19 A 308 LEU THR VAL PRO ASP ASP ILE ALA ALA ASN CYS ILE TYR SEQRES 20 A 308 LEU ASN ILE PRO ASN LYS GLY HIS VAL LEU LEU HIS ARG SEQRES 21 A 308 THR PRO GLU GLU TYR PRO GLU SER ALA LYS VAL TYR GLU SEQRES 22 A 308 LYS LEU LYS ASP HIS MET LEU ILE PRO VAL SER MET SER SEQRES 23 A 308 GLU LEU GLU LYS VAL ASP GLY LEU LEU THR CYS CYS SER SEQRES 24 A 308 VAL LEU ILE ASN LYS LYS VAL ASP SER SEQRES 1 B 308 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 308 LEU VAL PRO ARG GLY SER HIS MET ALA SER MET ALA GLY SEQRES 3 B 308 LEU GLY HIS PRO ALA ALA PHE GLY ARG ALA THR HIS ALA SEQRES 4 B 308 VAL VAL ARG ALA LEU PRO GLU SER LEU GLY GLN HIS ALA SEQRES 5 B 308 LEU ARG SER ALA LYS GLY GLU GLU VAL ASP VAL ALA ARG SEQRES 6 B 308 ALA GLU ARG GLN HIS GLN LEU TYR VAL GLY VAL LEU GLY SEQRES 7 B 308 SER LYS LEU GLY LEU GLN VAL VAL GLU LEU PRO ALA ASP SEQRES 8 B 308 GLU SER LEU PRO ASP CYS VAL PHE VAL GLU ASP VAL ALA SEQRES 9 B 308 VAL VAL CYS GLU GLU THR ALA LEU ILE THR ARG PRO GLY SEQRES 10 B 308 ALA PRO SER ARG ARG LYS GLU VAL ASP MET MET LYS GLU SEQRES 11 B 308 ALA LEU GLU LYS LEU GLN LEU ASN ILE VAL GLU MET LYS SEQRES 12 B 308 ASP GLU ASN ALA THR LEU ASP GLY GLY ASP VAL LEU PHE SEQRES 13 B 308 THR GLY ARG GLU PHE PHE VAL GLY LEU SER LYS ARG THR SEQRES 14 B 308 ASN GLN ARG GLY ALA GLU ILE LEU ALA ASP THR PHE LYS SEQRES 15 B 308 ASP TYR ALA VAL SER THR VAL PRO VAL ALA ASP GLY LEU SEQRES 16 B 308 HIS LEU LYS SER PHE CYS SER MET ALA GLY PRO ASN LEU SEQRES 17 B 308 ILE ALA ILE GLY SER SER GLU SER ALA GLN LYS ALA LEU SEQRES 18 B 308 LYS ILE MET GLN GLN MET SER ASP HIS ARG TYR ASP LYS SEQRES 19 B 308 LEU THR VAL PRO ASP ASP ILE ALA ALA ASN CYS ILE TYR SEQRES 20 B 308 LEU ASN ILE PRO ASN LYS GLY HIS VAL LEU LEU HIS ARG SEQRES 21 B 308 THR PRO GLU GLU TYR PRO GLU SER ALA LYS VAL TYR GLU SEQRES 22 B 308 LYS LEU LYS ASP HIS MET LEU ILE PRO VAL SER MET SER SEQRES 23 B 308 GLU LEU GLU LYS VAL ASP GLY LEU LEU THR CYS CYS SER SEQRES 24 B 308 VAL LEU ILE ASN LYS LYS VAL ASP SER HET LN7 A 286 15 HET LN7 B 286 15 HETNAM LN7 N~5~-[(1S)-1-AMINOPENTYL]-L-ORNITHINE FORMUL 3 LN7 2(C10 H23 N3 O2) FORMUL 5 HOH *49(H2 O) HELIX 1 1 SER A 24 ALA A 29 1 6 HELIX 2 2 ASP A 39 SER A 56 1 18 HELIX 3 3 PHE A 76 ASP A 79 5 4 HELIX 4 4 ALA A 95 LYS A 100 5 6 HELIX 5 5 GLU A 101 LEU A 112 1 12 HELIX 6 6 ASP A 127 GLY A 129 5 3 HELIX 7 7 ASN A 147 PHE A 158 1 12 HELIX 8 8 HIS A 173 SER A 176 5 4 HELIX 9 9 SER A 191 MET A 204 1 14 HELIX 10 10 ASP A 216 ASN A 221 5 6 HELIX 11 11 TYR A 242 GLU A 250 1 9 HELIX 12 12 MET A 262 VAL A 268 1 7 HELIX 13 13 LEU A 272 SER A 276 5 5 HELIX 14 14 SER B 24 ALA B 29 1 6 HELIX 15 15 ASP B 39 SER B 56 1 18 HELIX 16 16 VAL B 77 ASP B 79 5 3 HELIX 17 17 ALA B 95 SER B 97 5 3 HELIX 18 18 ARG B 98 LYS B 111 1 14 HELIX 19 19 ASP B 127 GLY B 129 5 3 HELIX 20 20 ASN B 147 PHE B 158 1 12 HELIX 21 21 HIS B 173 SER B 176 5 4 HELIX 22 22 SER B 191 SER B 205 1 15 HELIX 23 23 ASP B 216 ASN B 221 5 6 HELIX 24 24 TYR B 242 GLU B 250 1 9 HELIX 25 25 GLU B 264 ASP B 269 5 6 HELIX 26 26 LEU B 272 SER B 276 5 5 SHEET 1 A 3 GLN A 61 LEU A 65 0 SHEET 2 A 3 HIS A 15 ARG A 19 1 N VAL A 18 O LEU A 65 SHEET 3 A 3 VAL A 277 ILE A 279 -1 O VAL A 277 N VAL A 17 SHEET 1 B 3 ALA A 81 CYS A 84 0 SHEET 2 B 3 THR A 87 ILE A 90 -1 O LEU A 89 N VAL A 82 SHEET 3 B 3 ASN A 115 GLU A 118 1 O ASN A 115 N ALA A 88 SHEET 1 C 3 VAL A 131 PHE A 133 0 SHEET 2 C 3 PHE A 138 LEU A 142 -1 O PHE A 139 N LEU A 132 SHEET 3 C 3 VAL A 163 PRO A 167 1 O VAL A 166 N VAL A 140 SHEET 1 D 3 CYS A 178 GLY A 182 0 SHEET 2 D 3 LEU A 185 GLY A 189 -1 O ALA A 187 N SER A 179 SHEET 3 D 3 ASP A 210 VAL A 214 1 O LEU A 212 N ILE A 188 SHEET 1 E 3 ILE A 223 ILE A 227 0 SHEET 2 E 3 GLY A 231 HIS A 236 -1 O GLY A 231 N ILE A 227 SHEET 3 E 3 HIS A 255 PRO A 259 1 O MET A 256 N HIS A 232 SHEET 1 F 3 GLN B 61 LEU B 65 0 SHEET 2 F 3 HIS B 15 ARG B 19 1 N ALA B 16 O GLN B 61 SHEET 3 F 3 VAL B 277 ILE B 279 -1 O VAL B 277 N VAL B 17 SHEET 1 G 3 ALA B 81 CYS B 84 0 SHEET 2 G 3 THR B 87 ILE B 90 -1 O LEU B 89 N VAL B 82 SHEET 3 G 3 ASN B 115 GLU B 118 1 O ASN B 115 N ALA B 88 SHEET 1 H 3 VAL B 131 PHE B 133 0 SHEET 2 H 3 PHE B 138 LEU B 142 -1 O PHE B 139 N LEU B 132 SHEET 3 H 3 VAL B 163 PRO B 167 1 O VAL B 166 N LEU B 142 SHEET 1 I 3 CYS B 178 GLY B 182 0 SHEET 2 I 3 LEU B 185 GLY B 189 -1 O ALA B 187 N SER B 179 SHEET 3 I 3 ASP B 210 VAL B 214 1 O VAL B 214 N ILE B 188 SHEET 1 J 3 ILE B 223 ILE B 227 0 SHEET 2 J 3 GLY B 231 HIS B 236 -1 O GLY B 231 N ILE B 227 SHEET 3 J 3 HIS B 255 PRO B 259 1 O MET B 256 N HIS B 232 LINK SG CYS A 274 CZ LN7 A 286 1555 1555 1.99 LINK SG CYS B 274 CZ LN7 B 286 1555 1555 1.99 SITE 1 AC1 12 LEU A 30 ASP A 73 PHE A 76 GLU A 78 SITE 2 AC1 12 ASP A 79 ARG A 98 GLY A 129 ARG A 145 SITE 3 AC1 12 HIS A 173 VAL A 268 ASP A 269 CYS A 274 SITE 1 AC2 13 LEU B 30 ASP B 73 PHE B 76 GLU B 78 SITE 2 AC2 13 ASP B 79 ARG B 98 GLY B 129 HIS B 173 SITE 3 AC2 13 VAL B 268 ASP B 269 GLY B 270 CYS B 274 SITE 4 AC2 13 HOH B 289 CRYST1 47.210 80.900 74.090 90.00 90.13 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021182 0.000000 0.000048 0.00000 SCALE2 0.000000 0.012361 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013497 0.00000